1,407 research outputs found
Intraoperative detection of blood vessels with an imaging needle during neurosurgery in humans
Intracranial hemorrhage can be a devastating complication associated with needle biopsies of the brain. Hemorrhage can occur to vessels located adjacent to the biopsy needle as tissue is aspirated into the needle and removed. No intraoperative technology exists to reliably identify blood vessels that are at risk of damage. To address this problem, we developed an âimaging needleâ that can visualize nearby blood vessels in real time. The imaging needle contains a miniaturized optical coherence tomography probe that allows differentiation of blood flow and tissue. In 11 patients, we were able to intraoperatively detect blood vessels (diameter, \u3e500 ÎŒm) with a sensitivity of 91.2% and a specificity of 97.7%. This is the first reported use of an optical coherence tomography needle probe in human brain in vivo. These results suggest that imaging needles may serve as a valuable tool in a range of neurosurgical needle interventions
Imaging of non tumorous and tumorous human brain tissue with full-field optical coherence tomography
A prospective study was performed on neurosurgical samples from 18 patients
to evaluate the use of Full-Field Optical Coherence Tomography (FF-OCT) in
brain tumor diagnosis. FF-OCT captures en face slices of tissue samples at
1\mum resolution in 3D with a typical 200\mum imaging depth. A 1cm2 specimen is
scanned at a single depth and processed in about 5 minutes. This rapid imaging
process is non-invasive and 30 requires neither contrast agent injection nor
tissue preparation, which makes it particularly well suited to medical imaging
applications. Temporal chronic epileptic parenchyma and brain tumors such as
meningiomas, low- grade and high-grade gliomas, and choroid plexus papilloma
were imaged. A subpopulation of neurons, myelin fibers and CNS vasculature were
clearly identified. Cortex could be discriminated from white matter, but
individual glial cells as astrocytes (normal or reactive) or oligodendrocytes
were not observable. This study reports for the first time on the feasibility
of using FF-OCT in a real-time manner as a label-free non-invasive imaging
technique in an intra-operative neurosurgical clinical setting to assess
tumorous glial and epileptic margins
Recommended from our members
Looking for a perfect match: multimodal combinations of Raman spectroscopy for biomedical applications
Raman spectroscopy has shown very promising results in medical diagnostics by providing label-free and highly specific molecular information of pathological tissue ex vivo and in vivo. Nevertheless, the high specificity of Raman spectroscopy comes at a price, i.e., low acquisition rate, no direct access to depth information, and limited sampling areas. However, a similar case regarding advantages and disadvantages can also be made for other highly regarded optical modalities, such as optical coherence tomography, autofluorescence imaging and fluorescence spectroscopy, fluorescence lifetime microscopy, second-harmonic generation, and others. While in these modalities the acquisition speed is significantly higher, they have no or only limited molecular specificity and are only sensitive to a small group of molecules. It can be safely stated that a single modality provides only a limited view on a specific aspect of a biological specimen and cannot assess the entire complexity of a sample. To solve this issue, multimodal optical systems, which combine different optical modalities tailored to a particular need, become more and more common in translational research and will be indispensable diagnostic tools in clinical pathology in the near future. These systems can assess different and partially complementary aspects of a sample and provide a distinct set of independent biomarkers. Here, we want to give an overview on the development of multimodal systems that use RS in combination with other optical modalities to improve the diagnostic performance
Recommended from our members
Optical biopsy identification and grading of gliomas using label-free visible resonance Raman spectroscopy.
Glioma is one of the most refractory types of brain tumor. Accurate tumor boundary identification and complete resection of the tumor are essential for glioma removal during brain surgery. We present a method based on visible resonance Raman (VRR) spectroscopy to identify glioma margins and grades. A set of diagnostic spectral biomarkers features are presented based on tissue composition changes revealed by VRR. The Raman spectra include molecular vibrational fingerprints of carotenoids, tryptophan, amide I/II/III, proteins, and lipids. These basic in situ spectral biomarkers are used to identify the tissue from the interface between brain cancer and normal tissue and to evaluate glioma grades. The VRR spectra are also analyzed using principal component analysis for dimension reduction and feature detection and support vector machine for classification. The cross-validated sensitivity, specificity, and accuracy are found to be 100%, 96.3%, and 99.6% to distinguish glioma tissues from normal brain tissues, respectively. The area under the receiver operating characteristic curve for the classification is about 1.0. The accuracies to distinguish normal, low grade (grades I and II), and high grade (grades III and IV) gliomas are found to be 96.3%, 53.7%, and 84.1% for the three groups, respectively, along with a total accuracy of 75.1%. A set of criteria for differentiating normal human brain tissues from normal control tissues is proposed and used to identify brain cancer margins, yielding a diagnostic sensitivity of 100% and specificity of 71%. Our study demonstrates the potential of VRR as a label-free optical molecular histopathology method used for in situ boundary line judgment for brain surgery in the margins
Highâspeed Intraoperative Assessment of Breast Tumor Margins by Multimodal Ultrasound and Photoacoustic Tomography
Conventional methods for breast tumor margins assessment need a long turnaround time, which may lead to reâoperation for patients undergoing lumpectomy surgeries. Photoacoustic tomography (PAT) has been shown to visualize adipose tissue in small animals and human breast. Here, we demonstrate a customized multimodal ultrasound and PAT system for intraoperative breast tumor margins assessment using fresh lumpectomy specimens from 66 patients. The system provides the margin status of the entire excised tissue within 10 minutes. By subjective reading of three researchers, the results show 85.7% [95% confidence interval (CI), 42.0% â 99.2%] sensitivity and 84.6% (95% CI, 53.7% â 97.3%) specificity, 71.4% (95% CI, 30.3% â 94.9%) sensitivity and 92.3% (95% CI, 62.1% â 99.6%) specificity, and 100% (95% CI, 56.1% â 100%) sensitivity and 53.9% (95% CI, 26.1% â 79.6%) specificity respectively when crossâcorrelated with postâoperational histology. Furthermore, a machine learningâbased algorithm is deployed for margin assessment in the challenging ductal carcinoma in situ tissues, and achieved 85.5% (95% CI, 75.2% â 92.2%) sensitivity and 90% (95% CI, 79.9% â 95.5%) specificity. Such results present the potential of using mutlimodal ultrasound and PAT as a highâspeed and accurate method for intraoperative breast tumor margins evaluation
Recommended from our members
Biophysical basis of skin cancer detection using Raman spectroscopy
The goal of this dissertation is to study the potential of Raman spectroscopy in improving the clinical diagnosis of skin cancer, including two main applications: noninvasive screening of melanoma skin cancer and surgical margin detection of nonmelanoma skin cancer. Skin cancer is the most common type of malignancy, accounting for over 5.4 million cases and 10 thousand deaths per year in the United States alone. Like most cancers, the current âgold standardâ diagnosis relies on biopsy and histopathology, which is invasive, time-consuming, and costly. Moreover, large numbers of benign lesions are biopsied for melanoma diagnosis, resulting in substantial financial burden and patient discomfort. Therefore, an urgent need exists to develop a noninvasive, fast, and accurate method for skin cancer detection. The first part of the dissertation focuses on exploring the biophysical origin of in vivo melanoma detection. Our group has previously reported on the development of a clinical Raman spectroscopy system towards spectral biopsy of skin; however, the biochemical changes that Raman spectroscopy relies on for accurate melanoma diagnosis remained unclear. As a result, we proposed a biophysical inverse model to address this issue. To build the model, we established a custom confocal Raman microscope to extract in situ human skin constituents spanning normal and various diseased states. Our results indicate collagen, elastin, keratin, cell nucleus, triolein, ceramide, melanin, and water are the most important model components. Furthermore, collagen and triolein are the most relevant markers to discriminate malignant melanoma from benign nevi. The second part of the dissertation discusses the biophysical basis of nonmelanoma skin cancer margin delineation. We discovered the diagnostic markers to accurately differentiate tumor from normal skin, which is critical to maximize positive patient outcomes in skin cancer surgery. The biochemical changes derived from our model were highly correlated with histopathological diagnosis. We further demonstrated the feasibility of a superpixel acquisition approach for rapid classification of tumor boundaries in skin biopsies. Our results suggest Raman spectroscopy will be a powerful tool for intraoperative surgical guidanceBiomedical Engineerin
- âŠ